TR200801178A2 - Nateglinid ve surfaktan-ph ayarlayıcı sistemi içeren oral tablet kompozisyonları - Google Patents

Nateglinid ve surfaktan-ph ayarlayıcı sistemi içeren oral tablet kompozisyonları

Info

Publication number
TR200801178A2
TR200801178A2 TR2008/01178A TR200801178A TR200801178A2 TR 200801178 A2 TR200801178 A2 TR 200801178A2 TR 2008/01178 A TR2008/01178 A TR 2008/01178A TR 200801178 A TR200801178 A TR 200801178A TR 200801178 A2 TR200801178 A2 TR 200801178A2
Authority
TR
Turkey
Prior art keywords
surfactant
nateglinide
compositions containing
regulating system
oral tablet
Prior art date
Application number
TR2008/01178A
Other languages
English (en)
Inventor
Şahi̇n İnan
Odabaşi Serap
Koluman Selda
Sari Peli̇n
Taşar Nur
Original Assignee
Bi̇li̇m İlaç Sanayi̇ Ti̇caret A.Ş.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇li̇m İlaç Sanayi̇ Ti̇caret A.Ş. filed Critical Bi̇li̇m İlaç Sanayi̇ Ti̇caret A.Ş.
Priority to TR2008/01178A priority Critical patent/TR200801178A2/tr
Priority to PCT/TR2009/000029 priority patent/WO2009105049A1/en
Priority to EP09712103A priority patent/EP2257278A1/en
Publication of TR200801178A2 publication Critical patent/TR200801178A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]

Abstract

Bu buluş Nateglinid ile surfaktan: pH ayarlayıcı sistemin kombinasyonunu kapsayan farmasötik ürünler ve bunların hazırlanma prosesleri ile ilgilidir. Bu buluşla geliştirilen oral katı dozaj formundaki bileşik; a) Nateglinid veya bunun farmasötik olarak kabul edilebilir tuzlarını ve b) En az bir adet farmasötik olarak kabul edilebilir surfaktan-pH ayarlayıcı ajan sistemi içermesi ile karakteri edilmekte olup, ayrıca sözkonusu bileşiğin üretim prosesinin, nateglinidin bir veya birden fazla dolgu maddesi, dağıtıcı, bağlayıcı ve glidant ile karıştırılması; surfaktan:pH ayarlayıcı ajan sistemi ile granülasyonu, kurutulması, elenmesi, lubrikant ve glidant ilavesi, tablet baskısı ve film kaplama ajanı ile kaplanması aşamalarından oluşması açıklanmaktadır.
TR2008/01178A 2008-02-22 2008-02-22 Nateglinid ve surfaktan-ph ayarlayıcı sistemi içeren oral tablet kompozisyonları TR200801178A2 (tr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TR2008/01178A TR200801178A2 (tr) 2008-02-22 2008-02-22 Nateglinid ve surfaktan-ph ayarlayıcı sistemi içeren oral tablet kompozisyonları
PCT/TR2009/000029 WO2009105049A1 (en) 2008-02-22 2009-02-20 Oral tablet compositions containing nateglinide and surfactan ph adjusting agent
EP09712103A EP2257278A1 (en) 2008-02-22 2009-02-20 Oral tablet compositions containing nateglinide and surfactan ph adjusting agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2008/01178A TR200801178A2 (tr) 2008-02-22 2008-02-22 Nateglinid ve surfaktan-ph ayarlayıcı sistemi içeren oral tablet kompozisyonları

Publications (1)

Publication Number Publication Date
TR200801178A2 true TR200801178A2 (tr) 2009-09-23

Family

ID=40821905

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2008/01178A TR200801178A2 (tr) 2008-02-22 2008-02-22 Nateglinid ve surfaktan-ph ayarlayıcı sistemi içeren oral tablet kompozisyonları

Country Status (3)

Country Link
EP (1) EP2257278A1 (tr)
TR (1) TR200801178A2 (tr)
WO (1) WO2009105049A1 (tr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2515871B1 (en) 2009-12-23 2015-09-23 ratiopharm GmbH Solid pharmaceutical dosage form of ticagrelor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2307653T3 (es) * 2000-10-24 2008-12-01 Ajinomoto Co., Inc. Preparaciones que contienen nateglinida.
US7534913B2 (en) * 2002-07-18 2009-05-19 Teva Pharmaceutica Industries Ltd. Crystalline form of nateglinide
KR20080083071A (ko) * 2003-08-08 2008-09-12 아지노모토 가부시키가이샤 나테글리니드 함유 제제
US20070219250A1 (en) * 2003-11-28 2007-09-20 Romi Singh Pharmaceutical Compositions of Nateglinide
WO2005092319A1 (en) * 2004-03-29 2005-10-06 Ranbaxy Laboratories Limited Rapidly disintegrating pharmaceutical compositions comprising nateglinide and a disintegrant

Also Published As

Publication number Publication date
EP2257278A1 (en) 2010-12-08
WO2009105049A1 (en) 2009-08-27

Similar Documents

Publication Publication Date Title
EA201400972A1 (ru) Лекарственные формы немедленного высвобождения с защитой от несанкционированного применения
ME01488B (me) Derivati oksadiazola i njihovo korišćenje kao potencijatora metabotropnih glutamatnih receptora-842
BR112012024019A2 (pt) forma de dosagem de liberação controlada, e, método para liberar uma droga
RS54329B1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING RIFAXIMINE, PROCEDURES FOR THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF VAGINAL INFECTIONS
BRPI0606883A2 (pt) composição farmacêutica para administração oral, método para preparar um tablete, e, forma de dosagem sólida única
UY31698A (es) Preparacion solida de desintegracion oral
MA38399A1 (fr) Formulation sous forme de comprimé, utile pour traiter l'insuffisance cardiaque aiguë et l'insuffisance cardiaque chronique
TR200604349A2 (tr) Aripiprazol içeren farmasötik bileşimler
BR112013009153A2 (pt) formulação de ligante de fosfato para dosagem única.
JO2973B1 (en) Fumarate salt for (alpha-beta-R) -6-bromo-alpha-[2- (methylamino) ethyl-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinoline ethanol
MX362400B (es) Composicion farmaceutica que comprende olmesartan medoxomilo y rosuvastatina o su sal.
EA201300258A1 (ru) Композиции на основе налбуфина и их применение
NO20082047L (no) Sakte frigivende sammensetning, fremgangsmate for fremstilling derav og anvendelse av samme
SI2729130T1 (en) Combined formulations of darunavir
UA118562C2 (uk) Модулятори рецептора cxcr7
EA201390979A1 (ru) Композиции бензимидазолов с модифицированным высвобождением
BR122020011180B8 (pt) formulações injetáveis de compostos de tetraciclina
CL2009001267A1 (es) Compuestos derivados de triciclos nitrogenados, con actividad antibacteriana; procedimiento de preparacion; composicion farmceutica que los comprende; para el tratamiento de la tuberculosis.
TR201001903A2 (tr) Uzatılmış salımlı tiyokolşiklozit tablet.
TR200801178A2 (tr) Nateglinid ve surfaktan-ph ayarlayıcı sistemi içeren oral tablet kompozisyonları
FI3509595T3 (fi) Hydroksipyridonaattiaktinidi-/lantanididekorporaatioaineiden formulaatioita
NZ611026A (en) Pharmaceutical composition comprising citrate and bicarbonate salts, and use thereof for treating cystinuria
MX2009005329A (es) Composiciones farmaceuticas anticonvulsivas.
UA110933C2 (uk) Композиція для лікування есенціальної тромбоцитемії
TR201722039A2 (tr) Mesalazi̇ni̇n kati oral farmasöti̇k kompozi̇syonlari